Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
SOPERIOR FERTILIZER ANNOUNCES CHANGE OF DIRECTORS
-
Alliance Witan PLC - Net Asset Value
-
Jeito Capital announces significant participation in upsized $207.5 million Series C financing in Aviceda Therapeutics to advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials
-
PeanutUnbound Unveils $PUBD to Redefine Ethereum’s Future with Layer 2 Solutions
-
Goliath Reports Multiple High-Grade Gold Intercepts Within Several Holes, Inclusive Of 130.14 g/t AuEq (4.18 oz/t AuEq) Over 1 Meter In Surebet Zone and 33.80 g/t AuEq (1.09 oz/t AuEq) Over 3.10 Meter
-
Kraig Biocraft Laboratories Announces Breakthrough Transgenic Development Inspired by Darwin's Bark Spider
-
OraQuick® HIV Self-Test Now Approved for Use in Adolescents
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
BioCryst to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
ONL Therapeutics Appoints Penny Fleck as Chief Development Officer
-
Aya Gold & Silver Reports Zgounder Near Pit and At-Depth High-Grade Silver Drill Results
-
Eccogene Announces Formation of Scientific Advisory Board
-
Troilus Reflects on a Transformative Year in 2024 and Looks Ahead to Project Development in 2025
-
SRQ Resources: Mineral Rights Restored at Lac Brulé’s Target 900
-
Evergold Invites Parties to Partner with it to Advance its Flagship Golden Lion (Gold-Silver-Copper) and DEM (Gold-Antimony) Properties, BC
-
Italian Shoe Retailers Scarpe & Scarpe and Pittarosso Partner with Impact Analytics™ to Incorporate GenAI into Optimizing Inventory to Gain Insights and Drive Profitability
-
Lantronix Enables Development of a Powerful Military-Grade Gunshot Detection System at the Edge
-
Plug to Participate in Goldman Sachs Energy, CleanTech & Utilities Conference
-
MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia
-
Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences
-
PAC Machinery Brings Variety of Packaging Solutions to Inaugural Pack Expo Southeast
-
TradePending Introduces Value Watch, an Automated Tool Helping Auto Dealerships Build Lifelong Brand Awareness with Customers
-
Eddie Pinto Joins PlanSource as SVP, Product
-
Kymera Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14
-
Unicycive Therapeutics Announces Publication of Positive Oxylanthanum Carbonate (OLC) Dose Escalation Data in Clinical and Translational Science
-
Opthea Announces Publication in Diabetic Macular Edema
-
Mobilicom Secures Approximately $600,000 in Follow-On Production Scale Order from One of the Largest U.S.-based Drone Manufacturers for its Cybersecure Drone Data Link System
-
ACAMS Welcomes Industry Veteran Bill Fox to its Board of Directors
-
Micron Biomedical Secures $43 Million in Total Grant Support to Improve Coverage of Measles and Rubella Vaccine and Accelerate World’s First Phase 2 Trial of Needle-Free Drug and Vaccine Technology
-
Exodus Unveils New Swap Experience, Setting a New Standard for Crypto Transactions
-
Dorman appoints Tayfun Uner as President of its Light Duty business segment
-
Italian Shoe Retailers Scarpe & Scarpe and Pittarosso Partner with Impact Analytics™ to Incorporate GenAI into Optimizing Inventory to Gain Insights and Drive Profitability
-
CRAWFORD UNITED ACQUIRES RAHN INDUSTRIES
-
Immuneering Announces Positive Data Update from Three Pancreatic Cancer Arms of Ongoing Phase 2a Trial of IMM-1-104; Plans to Expand Trial with Additional Arms
-
Articul8 AI unveils “A8 Essential” - a new GenAI product that enables enterprises to rapidly explore insights from their complex data to unlock value
-
Gain Therapeutics Appoints Gene Mack as Chief Executive Officer and Director
-
ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025
-
HydroGraph Publishes 2025 CEO Letter to Shareholders
-
Akero Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Plug to Participate in Goldman Sachs Energy, CleanTech & Utilities Conference
-
iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio
-
CECO Environmental to Present at the 27th Annual Needham Growth Conference on January 17
-
Conavi Medical and Minnetronix Medical Publish In-Depth Collaboration Review
-
Liquidity Services Announces First Quarter Fiscal Year 2025 Earnings Conference Call
-
Regenx Receives Funding Support to Advance Proprietary Technology
-
YieldMax™ ETFs Announces Distributions on CONY ($0.8339), FIAT ($0.6530), NFLY ($0.5830), YMAX ($0.1395), YMAG ($0.1578) and Others
-
YieldMax™ ETFs Announces Distributions on BIGY ($0.5130) and SOXY ($0.5256)
-
BOOST Lottery Announces Gamified Global Lottery, BOOSTER Frenzy, and Marketplace Launch
-
Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
